Stremmel, Wolfgang

p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs

Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine

Cancer-related Molecular PathwaysCell death mechanisms and regulation

Cited by 878

TAp63α induces apoptosis by activating signaling via death receptors and mitochondria

Gressner, O., Schilling, T., Lorenz, K., Schulze Schleithoff, E., Koch, A., Schulze‐Bergkamen, H., Maria Lena, A., Candi, E., Terrinoni, A., Valeria Catani, M., et al. (2005) · The EMBO Journal

Cell death mechanisms and regulationCancer-related Molecular Pathways

Cited by 255

The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney

Kulaksiz, H., Theilig, F., Bachmann, S., Gehrke, S. G., Rost, D., Janetzko, A., Cetin, Y., & Stremmel, W. (2005) · Journal of Endocrinology

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 241

The Iron Regulatory Peptide Hepcidin Is Expressed in the Heart and Regulated by Hypoxia and Inflammation

Merle, U., Fein, E., Gehrke, S. G., Stremmel, W., & Kulaksiz, H. (2007) · Endocrinology

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 173

The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis

Pohl, J., Ring, A., Stremmel, W., & Stiehl, A. (2006) · European Journal of Gastroenterology & Hepatology

Liver Diseases and ImmunityGallbladder and Bile Duct Disorders

Cited by 111

Circulating phospholipid patterns in NAFLD patients associated with a combination of metabolic risk factors

Tiwari-Heckler, S., Gan-Schreier, H., Stremmel, W., Chamulitrat, W., & Pathil, A. (2018) · Nutrients

Liver Disease Diagnosis and TreatmentMetabolomics and Mass Spectrometry Studies

Cited by 96

FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis

Wannhoff, A., Hov, J. R., Folseraas, T., Rupp, C., Friedrich, K., Anmarkrud, J. A., Weiss, K. H., Sauer, P., Schirmacher, P., Boberg, K. M., et al. (2013) · Journal of Hepatology

Cholangiocarcinoma and Gallbladder Cancer StudiesLiver Diseases and Immunity

Cited by 94

Iron overload in adult Hfe-deficient mice independent of changes in the steady-state expression of the duodenal iron transporters DMT1 and Ireg1/ferroportin

Herrmann, T., Muckenthaler, M., van der Hoeven, F., Brennan, K., Gehrke, S. G., Hubert, N., Sergi, C., Gröne, H.-J., Kaiser, I., Gosch, I., et al. (2004) · Journal of Molecular Medicine

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 69

Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family

Schilling, T., Schleithoff, E. S., Kairat, A., Melino, G., Stremmel, W., Oren, M., Krammer, P. H., & Müller, M. (2009) · Biochemical and Biophysical Research Communications

Cancer-related Molecular PathwaysCell death mechanisms and regulation

Cited by 43

Pruritus is associated with severely impaired quality of life in patients with primary sclerosing cholangitis

Gotthardt, D. N., Rupp, C., Bruhin, M., Schellberg, D., Weiss, K. H., Stefan, R., Donnerstag, N., Stremmel, W., Löwe, B., Juenger, J., et al. (2014) · European Journal of Gastroenterology & Hepatology

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 41

Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis

Rupp, C., Friedrich, K., Folseraas, T., Wannhoff, A., Bode, K. A., Weiss, K. ‐., Schirmacher, P., Sauer, P., Stremmel, W., & Gotthardt, D. N. (2014) · Alimentary Pharmacology & Therapeutics

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 38

Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis

Rupp, C., Bode, K. A., Chahoud, F., Wannhoff, A., Friedrich, K., Weiss, K.-H., Sauer, P., Stremmel, W., & Gotthardt, D. N. (2014) · BMC Infectious Diseases

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 38

Control of diabetic hyperglycaemia and insulin resistance through TSC22D4

Ekim Üstünel, B., Friedrich, K., Maida, A., Wang, X., Krones-Herzig, A., Seibert, O., Sommerfeld, A., Jones, A., Sijmonsma, T. P., Sticht, C., et al. (2016) · Nature Communications

Adipokines, Inflammation, and Metabolic DiseasesMetabolism, Diabetes, and Cancer

Cited by 36

Inflammation but not biliary obstruction is associated with carbohydrate antigen 19-9 levels in patients with primary sclerosing cholangitis

Wannhoff, A., Rupp, C., Friedrich, K., Brune, M., Knierim, J., Flechtenmacher, C., Sauer, P., Stremmel, W., Hov, J. R., Schirmacher, P., et al. (2015) · Clinical Gastroenterology and Hepatology

Liver Diseases and ImmunityGallbladder and Bile Duct Disorders

Cited by 34